Samarina A.V., Mozaleva O.L., Martirosyan M.M., Skryabneva T.S.
Use of a fixed-dose antiretroviral drug in HIV-infected pregnant women
|
№2 / 2022
|
Dobin V.L., Panin I.V., Martynov V.A.
Risk factors for SARS-CoV-2 infection and peculiarities of viral shedding in patients with sarcoidosis
|
№2 / 2022
|
Makashova V.V., Ponezheva Zh.B., Omarova Kh.G., Burkova V.N., Sergun V.P., Gorelov A.V.
Experience with populin with dihydroquercetin in novel coronavirus infection
|
№2 / 2022
|
Ponezheva Zh.B., Grishaeva A.A., Burdakova E.A., Makashova V.V., Astrina O.S., Usenko D.V.
Possibilities of prevention and pathogenetic therapy of a new coronavirus infection
|
№2 / 2022
|
Asfandiyarova N.S.
Coronavirus infection and viruses of the Herpesviridae family
|
№2 / 2022
|
Omarova Kh.G., Makashova V.V., Ponezheva Zh.B., Ageikin A.V., Mitenkova D.M., Ploskireva A.A.
Post-COVID syndrome. Pathogenesis and clinical manifestations (Part 1)
|
№2 / 2022
|
Akimkin V.G., Davidova N.G., Ugleva S.V., Ponezheva Zh.B., Shabalina S.V.
Formation of COVID- 19 foci in closed collectives
|
№2 / 2022
|
Vasilkova V.V., Galimzyanov Kh.M., Kantemirova B.I.
Early prognostic markers of severe Astrakhan spotted fever
|
№2 / 2022
|
Ugleva S.V., Akimkin V.G., Ponezheva Zh.B., Vasilkova V.V., Shabalina S.V.
The comparative clinical characteristics of Astrakhan spotted fever and Crimean hemorrhagic fever in the Astrakhan Region
|
№2 / 2022
|
Solomay T.V., Semenenko T.A., Isaeva E.I., Vetrova E.N.
The role of active Epstein–Barr viral infection in the development of cerebrovascular diseases
|
№2 / 2022
|
Kashuba E.A., Rychkova O.A., Khanipova L.V., Khramova E.B., Lyubimtseva O.A., Ogoshkova N.V., Antonova M.V.
The immune status of school-age children with an acyclic course of tick-borne encephalitis depending on the premorbid state of the immune system
|
№2 / 2022
|
Ageikin A.V., Usenko D.V., Gorelov A.V., Kurmaeva D. Yu., Melnikov V.L., Kolesova E.V.
Pathogenetic features of the development and progression of heart damage in COVID-19
|
№2 / 2022
|